Form: 8-K

Current report filing

December 15, 2023

 

 

img51618503_0.jpg 

 

 

 

Ernst & Young s.r.l./S.E.N.C.R.L.

Ernst & Young LLP

900, boul. De Maisonneuve Ouest

Bureau 2300

Montréal (Québec) H3A 0A8

 

Tél./Tel : +1 514 875 6060

Téléc./Fax : +1 514 879 2600

ey.com

 

 

 

December 15, 2023

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

 

Commissioners:

We have read Item 4.01 of Form 8-K dated December 15, 2023, of Acasti Pharma Inc. and are in agreement with the statements contained in the first three paragraphs therein. We have no basis to agree or disagree with other statements of the registrant contained therein.

Very truly yours,

img51618503_1.jpg 

/s/ Ernst & Young LLP

 

 

Société membre d’Ernst & Young Global Limited / A member firm of Ernst & Young Global Limited

mx